Grafton, WI, United States of America

Paul Zizelman

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Cedarburg Pharmaceuticals, Inc.. Active years: 2012-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Zizelman. Retrieved from https://idiyas.com/inventor/paul-zizelman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul Zizelman: Innovator in Aromatase Inhibitors

Introduction

Paul Zizelman is a notable inventor based in Grafton, WI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of aromatase inhibitors. With a total of 2 patents to his name, Zizelman's work is recognized for its innovative approaches to drug formulation.

Latest Patents

Zizelman's latest patents include a method for preparing an aromatase inhibitor known as exemestane. This method involves a series of chemical reactions that utilize specific compounds to create an effective aromatase inhibitor. The process includes reacting a compound with a deprotonating agent and a halogenated alkyl compound, ultimately leading to the formation of the desired inhibitor.

Career Highlights

Paul Zizelman is currently employed at Cedarburg Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical innovations. His expertise in the field has contributed to the development of effective treatments for various medical conditions.

Collaborations

Zizelman collaborates with Kevin Kunnen, a fellow professional in the pharmaceutical industry. Their partnership enhances the research and development efforts at Cedarburg Pharmaceuticals, Inc.

Conclusion

Paul Zizelman is a distinguished inventor whose work in aromatase inhibitors has made a significant impact in the pharmaceutical field. His innovative methods and collaborations continue to drive advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…